Cytogen Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	38,599	31,201	54,838	15,878	30,288
Short-Term Investments	25.44	10,065	49.46	50.43	5,515
Trading Asset Securities	-	-	-	1,993	-
Cash & Short-Term Investments	38,624	41,266	54,887	17,922	35,803
Cash Growth	-30.83%	-24.82%	206.26%	-49.94%	-
Accounts Receivable	4,335	3,700	473.96	588.23	88.9
Other Receivables	309.4	836.34	259.88	164.15	137.48
Receivables	4,645	4,536	733.84	752.38	226.38
Inventory	2,100	1,723	25.3	131.47	-
Prepaid Expenses	173.78	184.8	234.71	186.73	73.13
Other Current Assets	854.26	368.71	122.29	396.76	7,487
Total Current Assets	46,397	48,079	56,003	19,389	43,589
Property, Plant & Equipment	7,591	6,828	4,980	3,104	2,808
Long-Term Investments	2,489	2,489	5,527	7,331	7,321
Goodwill	4,825	4,825	2,723	5,712	-
Other Intangible Assets	8,500	8,624	4,830	5,310	1,496
Long-Term Deferred Tax Assets	782.85	884.61	-	-	-
Other Long-Term Assets	1,059	748.49	386.96	375.1	313.75
Total Assets	71,644	72,478	74,450	41,220	55,528
Accounts Payable	1,635	1,666	206.64	189.2	112.63
Accrued Expenses	750.56	843.76	730.43	1,006	376.4
Short-Term Debt	4,031	327.92	7,980	25,758	3,280
Current Portion of Leases	841.63	917	556.4	474.98	442.66
Other Current Liabilities	6,356	960.5	1,274	6,502	2,579
Total Current Liabilities	13,614	4,715	10,747	33,930	6,791
Long-Term Debt	9,764	13,277	8,371	-	20,445
Long-Term Leases	408.24	349.93	669.13	191.3	456.46
Long-Term Deferred Tax Liabilities	-	-	549.23	838.98	-
Other Long-Term Liabilities	922.15	4,958	721.58	551.38	4,635
Total Liabilities	24,994	23,535	21,095	35,564	32,519
Common Stock	11,565	11,565	11,139	8,934	2,947
Additional Paid-In Capital	118,235	118,236	107,523	50,759	54,635
Retained Earnings	-87,620	-85,189	-68,072	-52,302	-33,531
Treasury Stock	-3,234	-3,234	-3,234	-3,234	-3,234
Comprehensive Income & Other	7,308	7,205	5,998	1,500	2,192
Total Common Equity	46,255	48,583	53,355	5,656	23,009
Minority Interest	394.96	359.78	-	-	-
Shareholders' Equity	46,650	48,943	53,355	5,656	23,009
Total Liabilities & Equity	71,644	72,478	74,450	41,220	55,528
Total Debt	15,045	14,872	17,576	26,424	24,624
Net Cash (Debt)	23,579	26,395	37,311	-8,502	11,179
Net Cash Growth	-43.89%	-29.26%	-	-	-
Net Cash Per Share	1033.25	1168.28	2040.21	-481.37	659.73
Filing Date Shares Outstanding	23.07	23.07	22.22	17.81	17.5
Total Common Shares Outstanding	23.07	23.07	22.22	17.81	17.5
Working Capital	32,782	43,364	45,256	-14,541	36,798
Book Value Per Share	2005.01	2105.94	2401.36	317.61	1314.64
Tangible Book Value	32,930	35,133	45,803	-5,365	21,513
Tangible Book Value Per Share	1427.41	1522.94	2061.45	-301.26	1229.19
Land	293.3	294	257.88	-	-
Buildings	2,244	2,249	1,973	-	-
Machinery	3,129	2,080	852.03	969.67	432.63
Construction In Progress	26.4	26.4	14	65.06	507.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.